Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group

Digestive and Liver Disease

Volumn 42, Issue 3, 2010, Pages 210-215

  Miyake, Yasuhiro ^a   Iwasaki, Yoshiaki ^a   Kobashi, Haruhiko ^a   Yasunaka, Tetsuya ^a   Ikeda, Fusao ^a   Takaki, Akinobu ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Acute hepatitis; Antinuclear antibody; Diagnosis; Immunoglobulin G; Smooth muscle antibody

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G; SMOOTH MUSCLE ANTIBODY;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INTERMETHOD COMPARISON; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEX DIFFERENCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 76049096989     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.06.013     Document Type: Article

References (25)

1. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 354 (2006) 54-66
2. Miyake Y., and Yamamoto K. Current status of autoimmune hepatitis in Japan. Acta Med Okayama 62 (2008) 217-226
3. Johnson P.J., and McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18 (1993) 998-1005
4. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
5. Papamichalis P.A., Zachou K., Koukoulis G.K., et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 4 (2007) 3-14
6. Germano V., Picchianti Diamanti A., Baccano G., et al. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 64 (2005) 1519-1520
7. Goldstein N.S., Bayati N., Silverman A.L., et al. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 114 (2000) 591-598
8. Pelli N., and Setti M. Atorvastatin as a trigger of autoimmune hepatitis. J Hepatol 40 (2004) 716
9. Berry P.A., and Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol 13 (2007) 2238-2239
10. Farias A.Q., Gonçalves L.L., Bittencourt P.L., et al. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. J Gastroenterol Hepatol 21 (2006) 887-893
11. Hennes E.M., Zeniya M., Czaja A.J., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48 (2008) 169-176
12. Desmet V.J., Gerber M., Hoofnagle J.H., et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19 (1994) 1513-1520
13. Wong G.L., Wong V.W., Choi P.C., et al. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 6 (2008) 1027-1035
14. Weismüller T.J., Wedemeyer J., Kubicka S., et al. The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 48 Suppl 1 (2008) S38-S57
15. Farrell G.C. Drug-induced hepatic injury. J Gastroenterol Hepatol 12 (1997) S242-S250
16. Wieckowska A., and Feldstein A.E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28 (2008) 386-395
17. Czaja A.J. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 48 (2008) 1540-1548
18. Montano-Loza A.J., Carpenter H.A., and Czaja A.J. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 46 (2007) 1138-1145
19. Al-Chalabi T., Boccato S., Portmann B.C., et al. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 45 (2006) 575-583
20. Czaja A.J. Behavior and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 30 (1999) 394-401
21. Miyake Y., Iwasaki Y., Kobashi H., et al. Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis. Hepatol Res 39 (2009) 241-246
22. Abe M., Hiasa Y., Masumoto T., et al. Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis. Hepatol Res 21 (2001) 213-219
23. Iwai M., Jo M., Ishii M., et al. Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis. Hepatol Res 38 (2008) 784-789
24. Ichai P., Duclos-Vallée J.C., Guettier C., et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 13 (2007) 996-1003
25. Scheuer P.L., and Lefkowitch J.H. Liver biopsy interpretation. 6th ed. (2000), W.B. Saunders, London